The expression of PIM kinases (PIM-1, PIM-2, and PIM-3) was analyzed in RA, PsA, and axSpA patient samples naïve to biologics or JAKi, some of which already received prior treatments with cDMARDs or corticosteroids. The gene discussed is PIM1; the disease is rheumatoid arthritis.